BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240329T092217Z
UID:2061cfc9-2a23-45d9-8b96-b4f67e6a789d
DTSTART:20230530T093000
DTEND:20230601T163000
CLASS:PRIVATE
DESCRIPTION:
\n
\nGlobal pharmaceutical R and D spend is increasing rapid
ly\, now topping a staggering $238bn globally. Increased spend\, coupled w
ith unpredictable inflation-related price increases and urgency to fast-tr
ack breakthroughs in exciting modalities to market means more pressure on
procurement to deliver than ever before.
\n
\nTo create much nee
ded visibility on how to combat against mounting risk facing supply and op
timize spend\, the 7th R and D Sourcing and Procurement in Pharma Summit r
eturns to Boston this May. As the dependable platform uniting 120+ Procure
ment\, Sourcing\, Category Management and Clinical Operations personnel\,
providing the knowledge and networking necessary to stay at the forefront
of technology and tactics to drive proactivity\, sustainability and profit
ability in your procurement operations.
\n
\nAs we expand the me
eting to two tracks dedicated to Discovery and Preclinical and Clinical pr
ocurement\, in 2023 you'\;re more comprehensively than ever before gain
ing intelligence necessary to inform your pipeline'\;s purchasing strat
egy.
\n
\nYour Unmissable Highlights for 2023:
\n
\nBu
ild risk mitigation into supply chains with the pre-identification of bott
lenecks to ensure timely allocation of R and D materials in-budget with No
vartis
\nScale promising cell and gene therapy pipelines to GMP and b
eyond with compliancy in mind with Atrara Biotherapeutics and Lexeo Therap
eutics
\nDrive efficiencies in early R and D with cost containment an
d anticipating the needs of scientists to deliver fast-paced programs with
Astellas Pharma and Editas Medicine
\nEstablish and maintain robust
clinical partnerships with the design of supplier selection metrics and me
asurement criteria with I-Mab BioPharma and GSK
\nExpedite R and D th
rough AI and predictive analytics which drive higher success rates in scie
ntific programs with Takeda and UCB
\n
\n
\nURLs:
strong>
\nTickets: \;https://go.evvnt.com/1594472-2?pid=1052
\nBrochure: \;<
a href="https://go.evvnt.com/1594472-3?pid=1052">https://go.evvnt.com/1594
472-3?pid=1052
\n
\n
\nPrices:
\n
Pharma and Biotech - Conference + 3 Workshops: USD 4096.00\,
\nPharma
and Biotech - Conference + 2 Workshops: USD 3597.00\,
\nPharma and B
iotech - Conference + 1 Workshop: USD 3098.00\,
\nPharma and Biotech
- Conference Only: USD 2599.00\,
\nSolution Providers - Conference +
3 Workshops: USD 6046.00\,
\nSolution Providers - Conference + 2 Work
shops: USD 5297.00\,
\nSolution Providers - Conference + 1 Workshop:
USD 4548.00\,
\nSolution Providers - Conference Only: USD 3799.00
SUMMARY:7th R and D Sourcing and Procurement in Pharma
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:7th R and D Sourcing and Procurement in Pharma
END:VALARM
END:VEVENT
END:VCALENDAR